Effects induced by Exe plus CBD in MCF-7aro cells
Schematic representation of the effects induced by Exe plus CBD in MCF-7aro cells. This combination compromises the binding of estrogens, produced by aromatase, to ERα, decreasing ERα protein levels and the transcription of some ERα-targeted genes, including EGR3. The reduction in EGR3 levels inhibits the activation of ERK1/2 signaling pathway, which prevents the inhibition of pro-caspase-8, that is converted to caspase-8, and, together with caspase-9, activates caspase-7, promoting apoptosis. Moreover, the effects of the combination on ERα modulate AR through an unknown crosstalk, contributing to the decreased EGR3 levels, avoiding the estrogen-like effect. Exe: Exemestane; CBD: cannabidiol; A: androstenedione; E: estrogens; ARO: aromatase; ER: estrogen receptor; AR: androgen receptor.
Publication
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors (2023) Cristina Ferreira Almeida, et al. Cancers (Basel). 2023 May;15(9). Figure: F9.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CBD | CBD | ncbigene_synonym | OPN1MW | 2652 |
| Homo sapiens | Primates | AR | AR | ncbigene_symbol | AR | 367 |
| Homo sapiens | Primates | ARO | ARO | ncbigene_synonym | CYP19A1 | 1588 |
| Homo sapiens | Primates | EGR3 | EGR3 | ncbigene_symbol | EGR3 | 1960 |
| Homo sapiens | Primates | AREG | AREG | ncbigene_symbol | AREG | 374 |
| Homo sapiens | Primates | TFF1 | TFF1 | ncbigene_symbol | TFF1 | 7031 |
| Homo sapiens | Primates | ERK1 | ERK1 | ncbigene_synonym | MAPK3 | 5595 |
| Homo sapiens | Primates | ERK1/2 | ERK2 | ncbigene_synonym | MAPK1 | 5594 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|